BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15804771)

  • 1. Interferon alpha-2a treatment for serpiginous choroiditis.
    Sobaci G; Bayraktar Z; Bayer A
    Ocul Immunol Inflamm; 2005 Feb; 13(1):59-66. PubMed ID: 15804771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of serpiginous choroiditis with alkylating agents.
    Akpek EK; Jabs DA; Tessler HH; Joondeph BC; Foster CS
    Ophthalmology; 2002 Aug; 109(8):1506-13. PubMed ID: 12153803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis.
    Bansal R; Gupta A; Gupta V; Dogra MR; Sharma A; Bambery P
    Ophthalmology; 2012 Nov; 119(11):2334-42. PubMed ID: 22892153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis.
    Vianna RN; Ozdal PC; Deschênes J; Burnier MN
    Can J Ophthalmol; 2006 Apr; 41(2):183-9. PubMed ID: 16767205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of interferon alpha-2a therapy in patients with Behcet's disease.
    Yalçindağ FN; Uzun A
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):439-43. PubMed ID: 22455657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments.
    Sobaci G; Erdem U; Durukan AH; Erdurman C; Bayer A; Köksal S; Karagul S; Bayraktar MZ
    Ophthalmology; 2010 Jul; 117(7):1430-5. PubMed ID: 20417563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Serpiginous Choroiditis with Chlorambucil: A Report of 17 Patients.
    Ebrahimiadib N; Modjtahedi BS; Davoudi S; Foster CS
    Ocul Immunol Inflamm; 2018; 26(2):228-238. PubMed ID: 27754769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis.
    Julian K; Langner-Wegscheider BJ; Haas A; De Smet MD
    Retina; 2013 Oct; 33(9):1943-8. PubMed ID: 23584698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile, treatment, and visual outcome of serpiginous choroiditis.
    Abrez H; Biswas J; Sudharshan S
    Ocul Immunol Inflamm; 2007; 15(4):325-35. PubMed ID: 17763131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term immunosuppressive treatment of serpiginous choroiditis.
    Akpek EK; Baltatzis S; Yang J; Foster CS
    Ocul Immunol Inflamm; 2001 Sep; 9(3):153-67. PubMed ID: 11815884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for choroidal neovascularisation in serpiginous choroiditis.
    Parodi MB; Iacono P; La Spina C; Knutsson KA; Mansour A; Arevalo JF; Bandello F
    Br J Ophthalmol; 2014 Apr; 98(4):519-22. PubMed ID: 24414400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile, treatment, and visual outcome of ampiginous choroiditis.
    Jyotirmay B; Jafferji SS; Sudharshan S; Kalpana B
    Ocul Immunol Inflamm; 2010 Jan; 18(1):46-51. PubMed ID: 20128650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular serpiginous choroiditis.
    Sahu DK; Rawoof A; Sujatha B
    Indian J Ophthalmol; 2002 Sep; 50(3):189-96. PubMed ID: 12355692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of intravitreal triamcinolone acetonide in serpiginous choroiditis.
    Wadhwa N; Garg SP; Mehrotra A
    Ophthalmologica; 2010; 224(3):183-7. PubMed ID: 19864928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with serpinginous choroiditis.
    Christmas NJ; Oh KT; Oh DM; Folk JC
    Retina; 2002 Oct; 22(5):550-6. PubMed ID: 12441719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive therapy in serpiginous choroiditis--case report and brief review of the literature.
    Vonmoos F; Messerli J; Moser HR; Prünte C; Flammer J; Haefliger IO
    Klin Monbl Augenheilkd; 2001 May; 218(5):394-7. PubMed ID: 11417346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.
    Krause L; Altenburg A; Pleyer U; Köhler AK; Zouboulis CC; Foerster MH
    J Rheumatol; 2008 May; 35(5):896-903. PubMed ID: 18412306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of remission by interferon-alpha in patients with chronic active ulcerative colitis.
    Sümer N; Palabiyikoğlu M
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):597-602. PubMed ID: 8590152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity.
    Thorne JE; Wittenberg S; Jabs DA; Peters GB; Reed TL; Kedhar SR; Dunn JP
    Ophthalmology; 2006 Dec; 113(12):2310-6. PubMed ID: 16996607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
    Kötter I; Eckstein AK; Stübiger N; Zierhut M
    Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.